Driehaus Capital Management LLC purchased a new stake in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 900,000 shares of the company’s stock, valued at approximately $9,112,000.
A number of other hedge funds also recently made changes to their positions in OACCU. Rangeley Capital LLC bought a new position in Oaktree Acquisition Corp. III Life Sciences in the 4th quarter valued at about $101,000. Athos Capital Ltd acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences during the fourth quarter valued at approximately $507,000. Kepos Capital LP bought a new stake in Oaktree Acquisition Corp. III Life Sciences during the fourth quarter worth approximately $709,000. Affinity Asset Advisors LLC acquired a new stake in Oaktree Acquisition Corp. III Life Sciences in the fourth quarter worth approximately $2,538,000. Finally, Whitebox Advisors LLC bought a new position in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter valued at $2,532,000.
Oaktree Acquisition Corp. III Life Sciences Stock Performance
Shares of OACCU stock opened at $10.54 on Friday. Oaktree Acquisition Corp. III Life Sciences has a 1 year low of $9.99 and a 1 year high of $10.60. The firm’s fifty day moving average price is $10.35.
About Oaktree Acquisition Corp. III Life Sciences
We are a newly organized blank check company incorporated on June 28, 2024, as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination.
Recommended Stories
- Five stocks we like better than Oaktree Acquisition Corp. III Life Sciences
- Basic Materials Stocks Investing
- Google Is Betting Big on Nuclear Reactors—Should You?
- What is diluted earnings per share (Diluted EPS)?
- Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs
- Earnings Per Share Calculator: How to Calculate EPS
- Why Nearly 20 Analysts Raised Meta Price Targets Post-Earnings
Want to see what other hedge funds are holding OACCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU – Free Report).
Receive News & Ratings for Oaktree Acquisition Corp. III Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oaktree Acquisition Corp. III Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.